— Know what they know.
Not Investment Advice

FBLG NASDAQ

FibroBiologics, Inc. Common Stock
1W: -3.6% 1M: -34.5% 3M: +39.9% YTD: -81.0% 1Y: -88.9%
$0.93
-0.01 (-0.87%)
After Hours: $0.95 (+0.02, +1.96%)
Weekly Expected Move ±10.0%
$1 $1 $1 $1 $1
NASDAQ · Healthcare · Biotechnology · Tech Score Strong Sell · Power 27 · $6.3M mcap · 5M float · 3.78% daily turnover · Short 43% of daily vol
Credit Risk of going bust: higher than 92% of companies Debt: 18.9% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.05 (down 95%), FibroBiologics, Inc. Common Stock would be worth roughly what it owes.
Total debt $1.5M against a stock market value of $6.3M.
Distance to default 1.22 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $664K (short-term plus half of long-term), stock volatility 139.3%; Altman Z'' -36.66. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Oct Typical
☁️
Cloudy
+0.0% YTD avg
2026 Now
☁️
Cloudy
Tracking typical
20yr Avg YTD
—
2026 YTD
—
Typical Vol
87%
Annualized
Monthly Weather Forecast
Jan
20yr
💨
+14.0%
50% win 128% vol
Feb
20yr
⛈️
-16.1%
0% win 234% vol
Mar
20yr
⛈️
-41.9%
0% win 185% vol
Apr
20yr
💨
+3.9%
33% win 100% vol
May
20yr
⛈️
-5.9%
33% win 112% vol
Jun
20yr
⛈️
-30.7%
0% win 164% vol
Jul
20yr
⛈️
-6.4%
67% win 86% vol
Aug
20yr
💨
+23.1%
33% win 160% vol
Sep
20yr
💨
+19.6%
33% win 158% vol
Oct
20yr
⛈️
-20.1%
0% win 87% vol
Now: -30.0%
Nov
20yr
⛈️
-21.8%
0% win 126% vol
Dec
20yr
⛈️
-20.8%
0% win 124% vol

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms